Status: Recruiting
Application of ⁶⁸Ga-FXX489 (NNS309) PET/CT Imaging in Diagnosis of Tumor Diseases.
A new radiotracer, 68Ga-FXX489 (NNS309), has been developed for tracking fibroblast activation protein (FAP) and visualizing the tumor stroma. The purpose of the study is to explore the diagnostic value of 68Ga-FXX489 (NNS309) PET/CT imaging in oncological diseases, to assess its safety, imaging characteristics, and biodistribution after administration.
Participants needed: 30
Trial details
Phase: Phase 1Age: 18-80Biological sex: AllType: InterventionalSponsor: Yi TianUpdated: Apr 3, 2026Locations: 1
Eligibility criteria
Patients with a high suspicion of oncological diseases. [+1]
Failure to sign the informed consent form. [+6]